title: Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.
abstract: Serologic assays that utilize herpes simplex virus (HSV) type-specific glycoproteins G-1 (HSV-1) and G-2 (HSV-2) to discriminate between antibodies against HSV-1 and HSV-2 are sensitive and specific. However, the high rates of seroreversion, defined as the change in an individual's antibody status from positive to negative over time, previously reported in longitudinal evaluations of glycoprotein G type-specific tests suggests that their use in HSV acquisitional studies would be problematic. To further explore the reliability of the glycoprotein G-based serologic tests, we evaluated HSV-1 and HSV-2 enzyme immunoassays from Focus Technologies in a longitudinal cohort of 1207 young women from Pittsburgh, Pa. On enrollment of the women in the study, HSV-1 and HSV-2 antibodies were detected in 46.6 and 24.9% of the women, respectively. Among the women with at least three visits, 3.4% (15 of 447) of those who were HSV-1 antibody positive had a subsequent negative result while fewer than 1% (2 of 227) of those who were HSV-2 antibody positive seroreverted. The median of mean positive index values for women who seroreverted to HSV-1 antibody was lower than that for women who remained seropositive (1.25 versus 7.06; P < 0.001). Similarly, the median of mean positive index values for women whose HSV-2 antibody status reverted from positive to negative was lower than that for those women who did not serorevert (1.83 versus 7.46; P = 0.02). Comparative Western blot analysis demonstrated that the lower positive index values, seen more often among the HSV seroreverters, often signified false-positive immunoassay results. Overall, the seroreversion rates were low; the use of glycoprotein G-based serologic tests for the measurement of HSV-1 and HSV-2 antibodies in incidence studies therefore appears warranted.
authors.affiliation: Department of Medicine, Division of Infectious Disease, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. rsitc@mail.magee.edu
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Cherpes
authors.forename: Rhoda L
authors.initials: RL
authors.lastname: Ashley
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Meyn
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Hillier
mesh_terms: D005260:Female; D018259:Herpesvirus 1, Human / Q000737:chemistry / Q000302:isolation & purification*; D018258:Herpesvirus 2, Human / Q000737:chemistry / Q000302:isolation & purification*; D006801:Humans; D007124:Immunoenzyme Techniques; D008137:Longitudinal Studies; D014759:Viral Envelope Proteins / Q000032:analysis*
chemical_list: D014759:Viral Envelope Proteins; C045464:glycoprotein G, herpes simplex virus type 2